We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEA
2001
Easterly Government Properties
DEA
$1.13B
| $848K | ﹤0.01% |
17,136
+1,354
| +9% | +$67.5K |
|
2002
Advanced Drainage Systems
WMS
$10.6B
| $847K | ﹤0.01% |
38,673
+665
| +2% | +$15.1K |
|
2003
German American Bancorp
GABC
$1.91B
| $846K | ﹤0.01% |
26,822
+752
| +3% | +$24.2K |
|
2004
TETRA Technologies
TTI
$1.14B
| $846K | ﹤0.01% |
207,905
+77,583
| +60% | +$349K |
|
2005
Pathward Financial
CASH
$1.86B
| $841K | ﹤0.01% |
28,524
+1,023
| +4% | +$31.6K |
|
2006
OceanFirst Financial
OCFC
$1.68B
| $841K | ﹤0.01% |
29,858
+1,443
| +5% | +$42K |
|
2007
Spok Holdings
SPOK
$228M
| $841K | ﹤0.01% |
44,282
+11,157
| +34% | +$216K |
|
2008
Travere Therapeutics
TVTX
$5.2B
| $839K | ﹤0.01% |
45,444
+2,218
| +5% | +$43.4K |
|
|
EPZM
2009
DELISTED
Epizyme, Inc
EPZM
| $838K | ﹤0.01% |
48,883
+1,448
| +3% | +$19.3K |
|
2010
FerroAtlántica
GSM
$594M
| $837K | ﹤0.01% |
81,001
+1,945
| +2% | +$20.5K |
|
2011
Forrester Research
FORR
$223M
| $836K | ﹤0.01% |
21,023
+5,501
| +35% | +$216K |
|
|
IBTX
2012
DELISTED
Independent Bank Group, Inc.
IBTX
| $835K | ﹤0.01% |
12,980
+419
| +3% | +$26.4K |
|
|
FMSA
2013
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $830K | ﹤0.01% |
113,230
+8,635
| +8% | +$90K |
|
|
WAIR
2014
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $829K | ﹤0.01% |
72,717
+8,481
| +13% | +$112K |
|
2015
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $827K | ﹤0.01% |
34,493
+1,100
| +3% | +$25.2K |
|
2016
Unisys
UIS
$209M
| $822K | ﹤0.01% |
58,931
+1,489
| +3% | +$20.6K |
|
|
ADAM
2017
Adamas Trust
ADAM
$815M
| $815K | ﹤0.01% |
33,020
+1,189
| +4% | +$30.7K |
|
|
AHT
2018
Ashford Hospitality Trust
AHT
$20.9M
| $814K | ﹤0.01% |
129
+8
| +7% | +$56.2K |
|
2019
Atlassian
TEAM
$25.6B
| $810K | ﹤0.01% |
27,044
+1,910
| +8% | +$53.9K |
|
2020
Preferred Bank
PFBC
$1.24B
| $802K | ﹤0.01% |
14,950
+657
| +5% | +$35.7K |
|
|
FIT
2021
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $802K | ﹤0.01% |
135,473
+6,086
| +5% | +$38.6K |
|
|
SDRL
2022
DELISTED
Seadrill Limited Common Stock
SDRL
| $802K | ﹤0.01% |
1,815
+121
| +7% | +$69.1K |
|
2023
Park Aerospace
PKE
$737M
| $801K | ﹤0.01% |
44,844
+10,340
| +30% | +$193K |
|
|
PTHN
2024
DELISTED
Patheon N.V.
PTHN
| $800K | ﹤0.01% |
30,382
+1,614
| +6% | +$47.2K |
|
|
COBZ
2025
DELISTED
CoBiz Financial,Inc
COBZ
| $798K | ﹤0.01% |
47,514
+1,171
| +3% | +$20K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.